NYSE$NHI

National Health Investors Inc · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

NHI's financial performance remained strong, marked by improvements in SHOP portfolio occupancy and strategic investments.

National Health Investors, Inc. (NHI) reported its Q3 2024 results, with a net income attributable to common stockholders of $0.65 per diluted share. The company is updating its 2024 annual guidance range. Fundamentals remain strong across much of the portfolio with occupancy and EBITDARM coverage improving sequentially from the second quarter across our major asset classes.

  • Net income attributable to common stockholders per diluted common share was $0.65.
  • NAREIT FFO per diluted common share was $1.03.
  • Normalized FFO per diluted common share was $1.03.
  • SHOP portfolio continues to improve with quarterly occupancy advancing 960 basis points year-over -year and 160 basis points sequentially to 88.6%.

Headline financials

Total Revenue

$82.9M

Previous: $80.1M+3.5%
EPS

$0.65

Previous: $1.08-39.8%
Capital Expenditures

-$13.4M

Previous: -$40.7M+67.0%
Free Cash Flow

$15.1M

Previous: -$11.3M+233.7%
Net Income

$28.5M

Previous: $29.3M-2.7%
Operating Income

$28.1M

Previous: $28.1M+0.2%
Gross Profit

$82.9M

Previous: $80.1M+3.5%

Revenue & EPS history

NHI · Revenue · Quarterly

$82.9M

Q3 2024+3.5%vs Q3 2023
Beat estimate in 13 of 15 quarters(87%)
ActualEstimate

Revenue by segment

NHI · $68.4M total across 1 segment · Q2 2021

  • Rental income
    $68.4M

Forward guidance

NHI is updating its 2024 annual guidance range which includes the following: NAREIT FFO per diluted common share to a range of $4.39 - $4.41 from $4.50 - $4.54; Normalized FFO per diluted common share to a range of $4.43 - $4.44 from $4.52 - $4.56; and Normalized FAD to a range of $201.8 million - $202.5 million from $200.1 million - $201.8 million.

Tailwinds

  • Expenses associated with transitioning properties
  • Continued fulfillment of existing commitments
  • SHOP NOI growth in a range of 28% - 30% year over year
  • Continued collection of deferred rents
  • Investments from subsequent events, but no incremental benefit from unidentified acquisitions

Headwinds

  • NAREIT FFO and Normalized FFO revised guidance is primarily due to lower cash lease revenue and interest income assumptions, and a $3.6 million non-cash increase to the credit loss reserve attributable to Senior Living Management.
  • Normalized FAD revised guidance is primarily due to acquisitions closed since August 2024 offset by lower cash lease revenue and interest income assumptions attributable to Senior Living Management.
  • Guidance range is based on several assumptions, many of which are outside the Company’s control and all of which are subject to change.
  • The guidance range may change if actual results vary from these assumptions.
  • One of cash basis tenants notified NHI in late September of their liquidity constraints which impacts 2024 guidance.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

+0.1%

Avg return

Earnings day

+0.6%

Avg return

5 days after

+1.3%

Avg return

30 days after

59%

40 / 68 earnings

Positive

+14.9%

Q3 2020

Best reaction

-7.9%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.4%-1.9%-9.4%
Q4 2025-4.2%-3.2%-6.3%
Q3 2025+1.8%+1.1%+4.1%
Q1 2025+0.5%+1.0%-6.2%
Q4 2024-0.2%+2.9%+4.8%
Q3 2024+1.1%+7.0%-0.4%
Q2 2024+3.0%+3.2%+13.8%
Q1 2024+1.4%+0.9%+2.8%
Q4 2023+6.6%+8.4%+16.5%
Q3 2023+0.5%-0.7%+7.8%
Q2 2023-7.5%-6.7%-9.4%
Q1 2023+7.6%+8.3%+8.0%
Q4 2022-7.9%-6.5%-17.5%
Q3 2022-1.4%+3.4%+2.1%
Q2 2022+2.6%+4.9%+4.5%
Q1 2022-3.4%+1.4%+12.8%
Q4 2021-3.2%-2.0%+6.4%
Q3 2021+1.4%+1.8%+1.4%
Q2 2021-6.2%-5.5%-9.7%
Q1 2021-3.1%-4.9%-5.6%
Q4 2020-0.6%+0.1%+7.5%
Q3 2020+14.9%+18.0%+20.7%
Q2 2020+0.1%-2.8%-1.0%
Q1 2020-4.2%-11.3%+19.2%
Q4 2019+1.4%+1.8%-57.5%
Q3 2019-2.0%-2.0%+1.0%
Q2 2019+2.1%+2.0%+3.9%
Q1 2019-1.2%+0.8%+3.4%
Q4 2018-6.9%-4.0%-5.7%
Q3 2018+1.6%+2.4%+8.0%
Q2 2018+1.0%+0.1%+3.1%
Q1 2018+1.9%+1.7%+6.7%
Q4 2017+0.0%+0.8%+7.5%
Q3 2017-2.9%-1.5%-0.6%
Q2 2017+1.0%+2.8%+6.7%
Q1 2017+2.5%+4.4%+5.1%
Q4 2016+0.7%+1.1%-3.9%
Q3 2016-0.3%-5.5%+1.1%
Q2 2016+0.6%+2.0%+3.4%
Q1 2016+1.9%
Q4 2015+3.8%
Q3 2015-0.1%
Q2 2015-1.9%
Q1 2015+1.5%
Q4 2014+0.4%
Q3 2014-0.7%
Q2 2014+2.6%
Q1 2014+1.5%
Q4 2013-1.0%
Q3 2013-0.7%
Q2 2013-0.0%
Q1 2013+3.3%
Q4 2012-1.1%
Q3 2012+1.3%
Q2 2012-2.7%
Q1 2012+1.2%
Q4 2011-2.4%
Q3 2011+0.8%
Q2 2011-5.4%
Q1 2010-2.5%
Q1 2011+0.1%
Q4 2008+0.2%
Q4 2010+0.2%
Q3 2010+1.6%
Q3 2009+1.6%
Q2 2010+0.9%
Q2 2009+0.9%
Q4 2009+0.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro